Clinical Trial of Peer Support in the ED (PCORI)
Launched by YALE UNIVERSITY · Aug 13, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help manage agitation in people who come to the emergency department (ED) at certain Yale-New Haven Health locations. The study will explore how well peer support, which means having someone who has experienced similar challenges help others, works for patients dealing with agitation and behavioral issues. Researchers want to find out if this approach is acceptable and practical for those in the ED.
To be part of this study, participants need to be 18 years or older, speak English, and arrive at one of the participating emergency departments with a behavioral health concern. This could include issues related to mental health, substance use, or other behaviors. Unfortunately, pregnant women, minors, and certain other groups cannot participate. If someone joins the study, they can expect to receive support from peers who understand their situation, which could help improve their experience in the emergency department. The trial is not yet recruiting participants, but it aims to provide valuable insights into how to better support patients experiencing agitation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • English-speaking
- • Arrives to one of the Yale-New Haven Health emergency departments (Yale-New Haven \[York Street \& St. Raphael's\], Greenwich, Bridgeport, Lawrence \& Memorial, and Westerly campuses)
- • Presents with a behavioral-related chief complaint (inclusive of neurocognitive, substance use/intoxication, mental health and other behavioral related presentations) as well as additional individuals at risk of developing agitation defined via a score of \>2 on the Brøset Violence Checklist
- Exclusion Criteria:
- • Pregnant women, minors (\<18 years old), prisoners, and institutionalized individuals
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Ambrose Wong, MD, MSEd, MHS
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported